SPEAKER_01 0:00

So imagine uh going to the doctor, right? Over the course of maybe three years, you get your blood drawn, it goes to the lab, and your scores for this one crucial blood clotting test come back. First it's a 38, then a 68, and then later it's a 52.

SPEAKER_00 0:15

Yeah, and most of us would see those numbers jumping around and just assume, you know, someone in the lab made a terrible mistake.

SPEAKER_01 0:20

Exactly. Or that the testing machines are just like wildly inaccurate. But what if, and this is the wild part, what if all of those numbers were completely medically accurate for you at the time?

SPEAKER_00 0:31

Aaron Powell Right. That scenario really strikes at the heart of, well, an incredibly pervasive myth in modern medicine. Because we're all sort of conditioned to view our lab results like they are, I mean, like they're stamped onto our DNA.

SPEAKER_01 0:44

Like it's just this fixed, immutable characteristic of who you are.

SPEAKER_00 0:46

Exactly. A permanent number.

SPEAKER_01 0:48

But to dismantle that illusion, welcome to our latest deep dive. Today we're exploring a really comprehensive medical article. It's titled Normal VWF Variation, the moving baseline, and it's by William Ayrd.

SPEAKER_00 1:01

And it's a fantastic piece of literature.

SPEAKER_01 1:03

It really is. The focus here is on something called von Willerbrand Factor, or VWF. Now, for anyone unfamiliar with this, VWF is this massive protein in your blood plasma. I like to think of it as sort of the molecular velcro of your circulatory system.

SPEAKER_00 1:20

That is a great way to put it, actually.

SPEAKER_01 1:22

Right. Because when you get a cut, VWF kind of unravels and acts like a net. It catches these tiny blood cells called platelets and just like sticks them to the injured blood vessel so you stop bleeding.

SPEAKER_00 1:32

Aaron Powell It's basically the ultimate first responder for your body. I mean, without it, your blood simply can't form a stable plug. And that leads to severe and sometimes life-threatening bleeding disorders.

SPEAKER_01 1:44

Aaron Powell So it's incredibly important. But treating a lab result for this vital protein like it's a fixed trait is well, it's essentially like looking at a single photograph of someone mid-jump and then just assuming they can naturally levitate.

SPEAKER_00 1:56

Yeah, that's exactly it.

SPEAKER_01 1:57

You're just seeing one frozen fraction of a second, you are completely missing the video. You know, you're missing the gravity, pulling them down, the context of how they got up there to begin with, and frankly, where they're gonna land.

SPEAKER_00 2:08

The photograph versus the video analogy perfectly illustrates the core diagnostic challenge here. Because every time, uh every time a needle goes into a patient's arm to measure VWF, the clinician is actually grappling with two entirely distinct questions. The first one is pretty straightforward, right? How much of this protein is physically measurable in the plasma today?

SPEAKER_01 2:28

Just a simple quantity check.

SPEAKER_00 2:30

Exactly. But the second question, the one that actually matters for a real diagnosis, is much deeper. It asks, does today's value actually represent the patient's underlying hemostatic state?

SPEAKER_01 2:41

And when we say, you know, hemostatic state, we are talking about the body's baseline balancing act, right? Between bleeding way too much and clotting way too much.

SPEAKER_00 2:49

Aaron Powell, right. And the baseline isn't just a single static dot on a chart. I mean, it is a living, breathing trajectory. The whole goal is to understand the patient's usual biology, not just the panic biology of this exact isolated second.

SPEAKER_01 3:02

Which is why understanding this concept extends way, way beyond just hematology. I mean, it completely sheafs how you should interpret any data point in your own life, whether it's your general health records or even your daily fitness tracking.

SPEAKER_00 3:15

Oh, absolutely. A number without biological context is basically just data without a story.

SPEAKER_01 3:19

Aaron Powell Okay, let's unpack this because the text points out that VWF is what medical professionals call an acute phase reactant.

SPEAKER_00 3:27

Yeah, and that classification is really the main driver of this uh minute-to-minute movement we see. An acute phase reactant is basically any protein whose plasma concentration increases or decreases in direct response to inflammation or tissue injury.

SPEAKER_01 3:42

Aaron Powell The mechanism behind that is just fascinating to me because the cells that line your blood vessels, the endothelial cells, they actually store up massive amounts of VWF in these little microscopic packets.

SPEAKER_00 3:53

They do, yeah. Like tiny emergency reserves.

SPEAKER_01 3:56

Right. So when your body experiences significant physical stress, like, say, a bad infection, a severe trauma, major surgery, or honestly, even just running a really grueling marathon, your body pumps out adrenaline and all these inflammatory signals.

SPEAKER_00 4:08

And those signals hit the blood vessels.

SPEAKER_01 4:10

Exactly. And it causes those little storage packets to just pop open and flood your entire bloodstream with extra VWF.

SPEAKER_00 4:17

And the evolutionary logic there is brilliant. I mean, if you are experiencing severe trauma or stress, your body essentially assumes you might be bleeding. So it preemptively dumps all that molecular velcro into the plasma just in case you need it.

SPEAKER_01 4:31

But wait, so if I just sprinted up a huge flight of stairs because I was like late for my doctor's appointment, or or if I'm just having a really, really stressful week at work, is my diagnostic test completely compromised? Like, do those minor stresses flood the system and completely ruin the baseline?

SPEAKER_00 4:47

Well, no. And that's an important distinction. The threshold for an actual acute phase response requires significant physiological strain.

SPEAKER_01 4:56

Okay. So a bad day at the office isn't going to ruin the test.

SPEAKER_00 4:59

Right. Exactly. Ordinary daily activity, you know, like climbing stairs or standard emotional stress, that won't trigger a massive dump of VWF that completely invalidates a test. However, a major infection, acute physical trauma, or a surgical procedure will absolutely flood the system. And that artificially inflates the number, which can easily mask a naturally lower baseline.

SPEAKER_01 5:21

Which dictates why clinicians always insist on testing during a state of quote unquote baseline health, right? Like when you are fully rested, uninjured, and not fighting off an illness.

SPEAKER_00 5:31

Precisely. You need the resting physiology to find the resting number.

SPEAKER_01 5:35

So on top of those stress-induced spikes, the source also details how our inherited biology modifies that resting number right from birth. And the most prominent example of this is our ABO blood group. Yes. The text mentions that people with typo blood naturally have lower average VWF levels compared to people with type A or B or A B.

SPEAKER_00 5:56

What's fascinating here is the sheer mechanics of how blood type actually affects a clotting protein. Because VWF is heavily coated in these complex sugar molecules.

SPEAKER_01 6:05

Like a protective layer.

SPEAKER_00 6:06

Yeah, exactly. Now, if you have type A or type B blood, you have these specific enzymes that add A or B sugar caps onto the VWF protein. But if you have type O blood, you completely lack those specific enzymes. So your VWF protein is essentially missing a chemical hat.

SPEAKER_01 6:25

A missing hat. And the body definitely notices that it's missing.

SPEAKER_00 6:29

Oh, it does. There are these specialized clearance cells in your liver called macrophages, and they constantly scan the bloodstream looking for proteins that need to be recycled.

SPEAKER_01 6:37

Okay.

SPEAKER_00 6:38

And because the typo VWF lacks those protective sugar caps, the macrophages spot it much easier. They grab onto it and they clear it from the plasma much more rapidly. A person with typo blood will clear VWF about 20% faster than someone with nano blood.

SPEAKER_01 6:53

Okay. I am going to push back on how this is used in practice, though, because this sounds like a massive loophole for missing a diagnosis.

SPEAKER_00 6:59

How do you mean?

SPEAKER_01 7:00

Well, are doctors supposed to just ignore a dangerously low clotting number if the person happens to have typo blood? Do they just say, well, their liver is clearing it faster because of their blood type, so there's absolutely nothing to worry about?

SPEAKER_00 7:11

Ah, I see. No, absolutely not. And current international guidelines explicitly warn against doing exactly that. Oh, good. Yeah. You cannot dismiss a clinically low VWF score just because a patient has typo blood. The blood type explains the mechanism of clearance, right? It tells us why the baseline sits lower. But it does not negate the clinical reality. Right.

SPEAKER_01 7:32

The person is still low.

SPEAKER_00 7:33

Exactly. If a typo patient has a low score and is sitting in your clinic with a history of severe nosebleeds and bruising, that low score is clinically significant. Biology provides the mechanism, but it does not provide an excuse to ignore a real-world bleeding problem.

SPEAKER_01 7:48

That makes a lot of sense. So we have this biology moving minute to minute based on stress, and it's constantly modified by these clearance rates in the liver based on blood type. But on a macro level, the patient's entire physical state changes over the course of decades.

SPEAKER_00 8:02

Decades of constant change, yes.

SPEAKER_01 8:03

A context of a human life is in constant motion. And the source material provides this incredible stress test for this exact concept: pregnancy.

SPEAKER_00 8:12

Oh, pregnancy completely reshapes the hemostatic system. The data clearly shows that during gestation, levels of VWF and another vital clotting protein called factor VII, they just naturally rise.

SPEAKER_01 8:25

And the mechanism there is purely hormone-driven, right? As estrogen levels skyrocket during pregnancy, that estrogen signals those endothelial cells to drastically ramp up their production of VWF. Right. The body is basically deliberately increasing its own hemostatic reserve. It's building up this immense clotting power to prevent catastrophic hemorrhage during childbirth.

SPEAKER_00 8:46

Which is an incredible evolutionary safeguard. But it creates a massive diagnostic blind spot for doctors. How so? Well, if a clinician tests a pregnant patient for von Willebrand disease during the third trimester, their hormone-inflated numbers will likely look completely normal or honestly even exceptionally high. The test answers the what is measurable today question perfectly, which is essential for safely managing the actual delivery. But it fails entirely at answering the what is the underlying state question.

SPEAKER_01 9:14

Because the moment the baby is delivered, those estrogen levels crash. And as the hormones crash, the VWF production just plummets right back down to the actual uninflated baseline.

SPEAKER_00 9:25

Exactly.

SPEAKER_01 9:25

That rapid drop can suddenly expose the patient to severe postpartum bleeding. It is this terrifying window where the baseline moves faster than the clinical expectation.

SPEAKER_00 9:35

It forces clinicians to really anticipate the crash rather than just trusting the elevated number on the paper in front of them.

SPEAKER_01 9:41

And it isn't just pregnancy shifting the baseline over time. The text also digs into longitudinal cohort data following patients as they age. As human beings get older, our blood vessels naturally sustain wear and tear.

SPEAKER_00 9:54

Just a natural part of aging.

SPEAKER_01 9:56

Right. And that accumulating endothelial damage causes a slow, steady increase in VWF levels over the years. So a patient diagnosed with type 1 von Willebrand disease at, say, age 20 might get retested at age 60, and their lab numbers have moved entirely into the normal range.

SPEAKER_00 10:12

Yeah, the lab report officially reads normal, which creates a really profound psychological and medical conundrum.

SPEAKER_01 10:18

It makes me think of like a dam on a river. When you're young, the water level behind the dam is low, and you can clearly see all the deep, dangerous cracks in the concrete walls. And those cracks are the bleeding disorder. Right. But as you age, the water level naturally rises, eventually covering up the cracks entirely. So from the surface, it looks perfectly smooth and normal, but the structural damage, the actual risk of the dam bursting, hasn't vanished just because the water level changed. Or to use another analogy, it's like your credit limit getting automatically raised by the bank as you get older. Just because you have more credit higher VWF doesn't mean your spending habits or financial risk history have suddenly vanished.

SPEAKER_00 10:59

That's a great way to think about it.

SPEAKER_01 11:00

So what does this all mean for the patient whose numbers suddenly look, you know, cured?

SPEAKER_00 11:05

Well, assuming the patient is cured is arguably the most dangerous leap a clinician can make. Laboratory normalization absolutely does not equate to clinical resolution.

SPEAKER_01 11:14

Wow, okay.

SPEAKER_00 11:15

Yeah. The patient's historical bleeding phenotype, meaning their actual lived tendency to bleed heavily during surgeries or dental procedures, that doesn't just evaporate because a protein level crept up over four decades.

SPEAKER_01 11:28

The history doesn't disappear just because the metric changed on a piece of paper?

SPEAKER_00 11:31

Precisely. The question clinicians must ask isn't has the number changed? Biology practically guarantees it will change. The necessary question is, what does the new number mean in light of their lifetime history? If a patient suffered severe bleeding episodes for decades, a newly normal lab result at age 65 doesn't rewrite their physical history. You still treat that patient with immense care, especially if they're heading into a major surgery.

SPEAKER_01 12:00

Okay, so the biology shifts, the patient ages, life happens, but the plot sickens even further because sometimes the patient's body doesn't change at all, the medical rule book changes.

SPEAKER_00 12:08

Oh, yes.

SPEAKER_01 12:09

The interpretation shifts right beneath our feet.

SPEAKER_00 12:11

Because our definitions of disease versus natural variants are constantly refined by new population data. We learn more, so we adjust.

SPEAKER_01 12:19

The text actually highlights how the 2021 International Guidelines literally moved the diagnostic goalposts for von Willebrand disease. And we should probably define the units here. These tests are usually measured in international units per deciliter or IUDL. Right. Basically, 100 IUDL is the average amount of VWF found in normal human plasma. Under the new rules of VWF level below 50 IUDL in a patient who has abnormal bleeding symptoms officially supports a diagnosis of type 1 Winelbrand disease. But if the level drops below 30 IUDL, it supports the diagnosis regardless of their bleeding history.

SPEAKER_00 12:55

And the complexity really multiplies when you realize different hospitals and institutions still argue over the terminology for the numbers in between.

SPEAKER_01 13:03

Really? Like they can't agree on what to call it?

SPEAKER_00 13:05

Exactly. Some institutions label a score of, say, 40 IUDL as low VWF, and they treat it as a risk factor rather than a disease. While others firmly diagnose it as a mild form of the disorder. So a patient with a perfectly stable score of 45 could be labeled completely differently depending on the year they were tested, the guideline their specific doctor prefers, and even just the specific hospital they walked into.

SPEAKER_01 13:30

That is wild. And beyond the guidelines, we haven't even touched on the sheer chaos of getting the blood from the patient's arm to the analytical machine in the first place.

SPEAKER_00 13:38

Uh, the pre-analytic variables.

SPEAKER_01 13:39

Yes. The text calls out these pre-analytic wildcards, things like sample collection, transport delays, temperature exposure. VWF is apparently a notoriously fragile protein.

SPEAKER_00 13:50

Extremely fragile.

SPEAKER_01 13:51

Right. So if the delivery truck carrying the blood sample gets stuck in traffic on a hot summer day, the proteins can literally degrade.

SPEAKER_00 13:58

Which means a falsely low VWF result might not represent a disease state at all. It might just be thermal degradation from a hot truck.

SPEAKER_01 14:04

And the labs themselves use different chemical techniques too. The text mentions older ristocetin cofactor methods versus newer platelet-dependent platforms.

SPEAKER_00 14:14

Right. The testing assays themselves have evolved.

SPEAKER_01 14:17

Yeah. And the older ristocetin method uses this antibiotic to artificially force the VWF to stick to platelets inside a test tube just so the lab tech can see how well it works. But sometimes a patient has a completely harmless genetic quark that makes their VWF immune to that specific antibiotic in the tube, even though their VWF works perfectly fine in their actual body.

SPEAKER_00 14:39

Right, an artifact of the test itself.

SPEAKER_01 14:40

Exactly. The machine spits out a terrible score, but the patient never actually bleeds abnormally. So I have to push back again here. If the test is this incredibly sensitive to a hot delivery truck or some random genetic quirk, and the numbers fluctuate naturally with stress and age anyway, why do doctors even bother doing repeat testing? Are we just fishing for the right number or waiting for statistical regression to the mean so we can just average things out?

SPEAKER_00 15:07

This raises an important question, and it really forces a complete redefinition of what repeat testing actually achieves because repeat testing is not an exercise in confirming a solitary number. It is fundamentally an act of interpretation.

SPEAKER_01 15:20

Okay, taking that a step further though, how does repeating a flawed process fix the interpretation?

SPEAKER_00 15:26

Well, when a clinician orders a second or third test, they are asking two things. Was that initial result reproducible? And was it representative of the underlying biological state? The goal isn't finding one magical true coordinate on a graph.

SPEAKER_01 15:41

Okay.

SPEAKER_00 15:41

The goal is inferring a credible range. By taking multiple snapshots under different physiological conditions, you know, maybe one when they are slightly stressed, one when they are perfectly rested, you account for those variables. You piece together the video we talked about, you map how the patient's specific body responds over time, establishing the boundaries of their unique biology.

SPEAKER_01 16:00

To truly anchor how all of these elements, the daily biology, the macro aging, the lab technicalities, and the clinical interpretation, how all of that collides, the text provides this brilliant real-world scenario, a tale of two patients.

SPEAKER_00 16:14

Yes.

SPEAKER_01 16:21

Here's where it gets really interesting. Imagine two completely different people walk into a clinic. They both get their blood drawn, it goes to the exact same lab, and the results come back with a VWF score of exactly 46 IUDL for both of them. Identical numbers down to the decimal.

SPEAKER_00 16:39

A completely matched data point.

SPEAKER_01 16:40

Right. So patient A is a healthy 19-year-old woman. She is being evaluated during her normal baseline health, no current illnesses, no recent marathons, perfectly rested. But she has a lifelong clinical history of heavy menstrual bleeding and easy bruising.

SPEAKER_00 16:54

So she is sitting at her true resting physiology, but presenting with a very strong symptomatic history.

SPEAKER_01 17:00

Exactly. Now look at patient B. He is a 72-year-old man who is currently recovering from a severe case of pneumonia and buried in his medical chart from three decades ago, back when he was in his forties, is a VWF score that tested at 28 IUDL.

SPEAKER_00 17:13

Quite a bit lower.

SPEAKER_01 17:13

Right. So they are both sitting in the clinic today, exact same number on the paper for both of them. 46. Do they have the same diagnosis?

SPEAKER_00 17:20

Not even close. And let's break down the mechanics of why. For the 19-year-old patient A, her score of 46 combined with her active bleeding symptoms, firmly supports a type 1 von Willebrand disease diagnosis under the 2021 guidelines.

SPEAKER_01 17:34

Because she's symptomatic and under 50.

SPEAKER_00 17:36

Exactly. Yeah. And she is rested, so the number isn't artificially inflated by stress. Her biology, her symptoms, and the new guidelines all align perfectly.

SPEAKER_01 17:45

The number matches her reality.

SPEAKER_00 17:47

But for the 72-year-old patient B, his current number of 46 is completely clouded by modifiers. He is aging, which we know dries VWF up naturally due to endothelial wear and tear.

SPEAKER_01 17:59

Right, the dam filling up with water.

SPEAKER_00 18:01

Yes. But more importantly, he is recovering from acute pneumonia. That major lung inflammation sends inflammatory signal throughout his entire body, triggering those endothelial cells to dump extra VWF into his plasma. His 46 is a massive acute phase spike.

SPEAKER_01 18:16

It's totally masking his true baseline.

SPEAKER_00 18:19

Precisely. For him, that historical score of 28 IUDL from 30 years ago is still the absolute most relevant anchor for understanding his actual bleeding risk. So today, the numbers on the page are identical. But the clinical interpretation is entirely fundamentally different.

SPEAKER_01 18:38

Aaron Ross Powell That is just staggering to think about. The exact same measurement means you have a confirmed bleeding disorder for one person and your body is just temporarily fighting off a lung infection for the other.

SPEAKER_00 18:49

Aaron Powell And we connect this to the bigger picture. This scenario defines what we call clinical discordance.

SPEAKER_01 18:56

Discordance.

SPEAKER_00 18:56

Yeah. It happens when the patient's live story and the lab numbers clash, or when two patients look mathematically identical on paper, but are biologically opposite in reality. And discordance shouldn't frustrate the clinician or the patient. It should spark intense curiosity.

SPEAKER_01 19:11

Right. It's not a dead end.

SPEAKER_00 19:13

Not at all. It is not a diagnostic failure. It is vital diagnostic information.

SPEAKER_01 19:17

It's the ultimate clue that forces you to look deeper than the spreadsheet. I mean, if the number doesn't match the story, maybe it is an acquired disorder caused by another disease entirely. Exactly. Or maybe a new medication is altering the clearance rate in the liver. Or maybe the patient has an anatomic issue, like a physical structural source of bleeding, and their clotting proteins are actually working perfectly fine.

SPEAKER_00 19:38

The discordance demands that we treat the human being, not the piece of paper.

SPEAKER_01 19:42

So synthesizing everything we've explored from William Ayrd's research, the core lesson here is that we have to stop looking at medical data in a vacuum. You cannot just glance at a single laboratory value and assume you completely understand the whole biological system.

SPEAKER_00 19:57

You really can't.

SPEAKER_01 19:57

You have to interrogate the data. Why was it measured today of all days? What specific chemical assay was used in the lab? What was the patient's physiological baseline at that exact moment? And above all, does this solitary number align with their lived physical history? Because the laboratory value is measured once, but the patient has been changing for years.

SPEAKER_00 20:18

And for anyone listening, you know, navigating your own health journeys, this means learning to fiercely advocate for context. When you get a lab result back and there's a glaring red exclamation point next to a number, remember the photograph versus the video.

SPEAKER_01 20:32

Right.

SPEAKER_00 20:33

Do not panic over a single dot on a graph. Look at your trajectory. Examine the context of your life that week. Were you fighting off a virus? Were you under immense physiological stress? Did the sample get compromised in transit on a hot day?

SPEAKER_01 20:48

Yeah.

SPEAKER_00 20:48

Bring those contextual clues to your doctor because your life provides the actual meaning to their metrics.

SPEAKER_01 20:54

We started this exploration talking about a photograph of someone mid-jump and the sheer danger of assuming they can levitate just from one frozen frame. But internalizing how rapidly our biological baselines move leaves me with this really provocative thought. Yeah, because we are rapidly entering the era of continuous biometric tracking. Smartwatches, sleep rings, and even internal monitors are becoming incredibly sophisticated. If our medical baselines are constantly moving based on adrenaline, inflammation, exercise, and age, what happens if we eventually develop technology to track hemostatic markers like VWF Live 24-7?

SPEAKER_00 21:30

Wow, a continuous real-time feed of your internal clotting cascade beamed directly to your smartphone.

SPEAKER_01 21:37

Exactly. Will seeing our internal biology constantly fluctuating in real time just lead to a society plagued by hyper anxiety? I mean, imagine your watch buzzing with an alert because your VWF spiked just from running to catch a bus. That sounds exhausting. Right. Or will it finally give us the video we've been missing all along? Will a continuous feed permanently map out our unique, dynamic human trajectories so we never, ever have to guess our baseline again? It is definitely something to ponder the next time you glance at the heart rate monitor on your wrist. Thank you for joining us on this deep dive. Stay curious, keep investigating the context, and remember you are infinitely more complex than a single point of data. Catch you next time.